Effects of <i>Bifidobacterium longum longum</i> 35624® on the Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: Results of the Multicenter Observational Program SAGA
Aim: to evaluate the effects of the probiotic Symbiosys Alflorex (Bifidobacterium longum longum 35624®) on the symptoms and quality of life in patients with irritable bowel syndrome (IBS).Materials and methods. A multicenter, observational program (SAGA) was conducted to evaluate the effects of Symb...
Saved in:
| Main Authors: | V. T. Ivashkin, E. A. Poluektova, Z. A. Mamieva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2024-12-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/1371 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of Bifidobacterium longum 35624 in the treatment of patients with irritable bowel syndrome: a systematic review
by: D. Andreev, et al.
Published: (2024-06-01) -
Determination of Probiotics Prescription Indications in Patients with Irritable Bowel Syndrome (Materials of the Expert Council and Literature Review)
by: V. T. Ivashkin, et al.
Published: (2022-08-01) -
Selection and in vitro Probiotic Properties of Bifidobacterium longum subsp. longum with Anti-diabetic Activity from the Intestinal Tract of Chinese Tajik Children
by: LI Si, AN Meiling, LI Longlong, ZHANG Ruirui, SUN Hailong, NI Yongqing
Published: (2025-05-01) -
Multi-omics analyses the effect of Bifidobacterium longum subsp. longum BL21 supplementation on overweight and obese subjects: a randomized, double-blind, placebo-controlled study
by: Xiaoya Wang, et al.
Published: (2025-07-01) -
Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11
by: Alexander Bertuccioli, et al.
Published: (2025-05-01)